GeetikaSrivastavaMDMSPH

Oncology • Silver Spring, MD

Gastrointestinal Cancer

Medical Officer- FDA, Division of Oncology

Join to view full profile

Dr. Srivastava is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Srivastava's full profile

Already have an account?

Office
FDA White Oak Campus
10903 New Hampshire Ave
Silver Spring, MD 20993

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2010 - 2014
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Internal Medicine, 2007 - 2010
University of Texas, School of Public Health- MD Anderson Cancer CenterMSPH, Public Health- Epidemiology, GPA 4.0, 2005 - 2007
All India Institute of Medical SciencesClass of 2004

Certifications & Licensure

CO State Medical License 2013 - 2025
MN State Medical License 2010 - 2014
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
American Board of HematologyHematology
American Board of Medical OncologyMedical Oncology

Publications & Presentations

PubMed

1 citations
A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma.
Elizabeth R Kessler, Eryn Callihan, Junxiao Hu, Corbin Eule, Geetika Srivastava
Cancer Research Communications. 2023-06-01
13 citations
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer
Steven R. Alberts, Tiffany M. Yu, Robert J. Behrens, Lindsay A. Renfro, Geetika Srivastava
Pharmacoeconomics. 2014-08-26
44 citations
Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients
Geetika Srivastava, Lindsay A. Renfro, Robert J. Behrens, Margarita Lopatin, Calvin Chao
The Oncologist. 2014-05-01

Journal Articles

Prospective evaluation of a 12-gene assay on treatment recommendations in stage 2 colon cancer patients
Geetika Srivastava, Lindsay Anne Renfro, Robert J. Behrens, Margarita Lopatin, Calvin Chao, Gamini S. Soori, Shaker R. Dakhil, Rex Bradford Mowat, J. Phillip Kuebler, ..., Oncologist, 2014
Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma.
Kourelis TV, Kumar SK, Srivastava G, Gertz MA, Lacy MQ, Buadi FK, Kyle RA, Dispenzieri A., Leukemia, 2014
Real-world comparative economics of a 12-gene assay for prognosis in stage II colon cancer
Steven R. Alberts, Tiffany Yu, Robert J. Behrens, Lindsay Anne Renfro, Geetika Srivastava,Gamini S. Soori, Shaker R. Dakhil, Rex Bradford Mowat, J. Phillip Kuebler, Ge..., Oncologist, 2014
Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma
Geetika Srivastava, Vishal Rana, Martha Q Lacy, Morie A Gertz, Angela Dispenzieri, Suzanne R. Hayman, Francis K. Buadi, David Dingli, John A. Lust, Steven R. Zeldenrus..., Leukemia, 2013
Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy
Taxiarchis V. Kourelis, Shaji Kumar, Geetika Srivastava, Morie Gertz, Martha Q. Lacy, Francis Buadi, Suzanne Hayman, Steven Zeldenrust, Nelson Leung, Robert A. Kyle, S..., American Journal of Hematology, 2013
Risk of intracranial hemorrhage and cerebrovascular accident in non small cell lung cancer brain metastasis.
Srivastava G, Rana V, Wallace S, Taylor S, Debnam M, Huang Y, Feng L, Suki D, Karp D, Stewart D, Oh YW, Journal of Thoracic Oncology, 2009
Currying the heart: Curcumin and cardioprotection
Srivastava G, Mehta JL, J Cardiovasc Pharmacol Ther, 2009
Join now to see all

Press Mentions

Colorado Springs Top Doctors 2018October 9th, 2018